MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2024 · 96 positions · Total reported value $2.93B · Top-10 concentration 43.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2024 13F filing, MONTANOVA CAPITAL, LLC disclosed 96 equity positions with a combined reported value of $2.93B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were BHVN ($209.92M), SPY ($205.13M), ARQT ($158.79M). By sector, the heaviest allocations are Health Care 45.0%, Technology 13.4%. Versus the prior quarter, allocation shifted toward Health Care (+3.3pp), Industrials (+1.7pp) and away from Technology (-2.3pp), Communication Services (-2.7pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 69% of names.

The largest new positions opened in Q4 2024 were LEGN ($113.77M), IMTX ($36.01M), RCKT ($32.27M).

Of the 14 positions fully exited versus the prior quarter, the largest were AAPL ($78.32M), ACLX ($57.62M), RPRX ($52.80M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • LEGN LEGEND BIOTECH CORP · $113.77M
  • IMTX IMMATICS N.V · $36.01M
  • RCKT ROCKET PHARMACEUTICALS INC · $32.27M
  • TGTX TG THERAPEUTICS · $29.50M
  • BA BOEING CO · $27.47M
  • CZR CAESARS ENTERTAINMENT INC NE · $25.81M
  • APLS APELLIS PHARMACEUTICALS INC · $25.31M
  • DDOG DATADOG INC · $25.21M

Fully Exited (vs previous quarter)

  • AAPL APPLE INC · prev qtr: $78.32M
  • ACLX ARCELLX INC · prev qtr: $57.62M
  • RPRX ROYALTY PHARMA PLC · prev qtr: $52.80M
  • T AT&T INC · prev qtr: $50.28M
  • KDP KEURIG DR PEPPER INC · prev qtr: $26.35M
  • LVS LAS VEGAS SANDS CORP · prev qtr: $24.37M
  • INTC INTEL CORP · prev qtr: $23.46M
  • PINS PINTEREST INC · prev qtr: $19.94M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 45.0%
Technology 13.4%
Financials 5.6%
Other 17.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 5.62M $209.92M 7.15%
7.15%
Add
2 350.00K $205.13M 6.99%
6.99%
Reduce
3 11.40M $158.79M 5.41%
5.41%
Add
4 1.44M $120.19M 4.10%
4.10%
Hold
5 3.50M $113.77M 3.88%
3.88%
New
6 8.96M $113.16M 3.86%
3.86%
Add
7 1.61M $111.26M 3.79%
3.79%
Reduce
8 170.34K $99.73M 3.40%
3.40%
Add
9 10.20M $79.79M 2.72%
2.72%
Add
10 351.28K $77.07M 2.63%
2.63%
Hold
11 464.14K $76.66M 2.61%
2.61%
Hold
12 1.14M $70.84M 2.41%
2.41%
Add
13 345.91K $68.31M 2.33%
2.33%
Reduce
14 163.63K $66.08M 2.25%
2.25%
Reduce
15 2.25M $59.83M 2.04%
2.04%
Add
16 6.78M $50.53M 1.72%
1.72%
Add
17 118.40K $49.90M 1.70%
1.70%
Add
18 1.15M $48.44M 1.65%
1.65%
Hold
19 514.92K $46.99M 1.60%
1.60%
Reduce
20 251.64K $44.87M 1.53%
1.53%
Add
21 5.08M $44.22M 1.51%
1.51%
Reduce
22 245.53K $42.62M 1.45%
1.45%
Add
23 74.20K $42.49M 1.45%
1.45%
Reduce
24 4.91M $41.61M 1.42%
1.42%
Add
25 337.42K $40.76M 1.39%
1.39%
Reduce
26 436.39K $40.38M 1.38%
1.38%
Reduce
27 75.20K $38.04M 1.30%
1.30%
Reduce
28 226.32K $37.71M 1.28%
1.28%
Reduce
29 5.07M $36.01M 1.23%
1.23%
New
30 397.68K $35.52M 1.21%
1.21%
Add
31 200.66K $33.47M 1.14%
1.14%
Hold
32 2.57M $32.27M 1.10%
1.10%
New
33 12.32M $30.91M 1.05%
1.05%
Reduce
34 103.64K $30.04M 1.02%
1.02%
Hold
35 738.41K $29.53M 1.01%
1.01%
Reduce
36 980.00K $29.50M 1.00%
1.00%
New
37 155.20K $27.47M 0.94%
0.94%
New
38 772.41K $25.81M 0.88%
0.88%
New
39 793.19K $25.31M 0.86%
0.86%
New
40 176.45K $25.21M 0.86%
0.86%
New
41 1.72M $25.20M 0.86%
0.86%
Hold
42 180.76K $24.27M 0.83%
0.83%
New
43 12.34M $20.86M 0.71%
0.71%
Hold
44 3.69M $20.53M 0.70%
0.70%
Hold
45 139.99K $20.24M 0.69%
0.69%
Add
46 200.65K $19.48M 0.66%
0.66%
New
47 115.44K $17.65M 0.60%
0.60%
Add
48 38.34K $16.09M 0.55%
0.55%
New
49 3.34M $15.69M 0.54%
0.54%
Add
50 5.73M $14.16M 0.48%
0.48%
Hold

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, MONTANOVA CAPITAL, LLC reported 96 equity positions worth $2.93B in aggregate; its largest disclosed positions were BHVN ($209.92M), SPY ($205.13M), ARQT ($158.79M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $2.93B of long equity holdings across 96 positions as of 2024-Q4. Top-10 holdings account for 43.9% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →